Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Current Taxes: 2024

Historic Current Taxes for Adma Biologics (ADMA) over the last 1 years, with Dec 2024 value amounting to $3.5 million.

  • Adma Biologics' Current Taxes was N/A to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is N/A change from last year.
  • As of FY2024, Adma Biologics' Current Taxes stood at $3.5 million.
  • Over the past 5 years, Adma Biologics' Current Taxes peaked at $3.5 million during FY2024, and registered a low of $3.5 million during FY2024.
  • Moreover, its 1-year median value for Current Taxes was $3.5 million (2024), whereas its average is $3.5 million.